Discover the remarkable benefits of the Iris Versicolor 30C Homeopathic Remedy, specially formulated by Urenus. This product contains 200 pure sucrose pellets that are lactose-free, making it an ideal choice for individuals with dietary restrictions. At Urenus, we pride ourselves on adhering to the original procedures established by Dr. Samuel Hahnemann, the founder of homeopathy.
The Iris Versicolor remedy is created using highly diluted natural substances, which are carefully selected to ensure maximum efficacy while maintaining safety. Our commitment to quality is unwavering, as we utilize high-quality raw materials in the production of our homeopathic medicines. Each pellet is designed to dissolve under the tongue, promoting rapid absorption and effectiveness.
This homeopathic remedy is free from known side effects and drug interactions, allowing you to use it with confidence. However, it is essential to note that this product is intended for informational purposes only. It should not be considered as a substitute for professional medical advice. If symptoms persist for more than three days or worsen, we strongly recommend consulting a physician.
For optimal results, it is preferable to take the pellets apart from meals. Additionally, if you are pregnant or breastfeeding, we advise speaking with a health professional before use. It is vital to keep this product out of reach of children to ensure safety.
In summary, the Iris Versicolor 30C Homeopathic Remedy offers a natural approach to wellness, combining traditional manufacturing methods with high-quality ingredients. Experience the difference that Urenus can bring to your health routine today!
Product Name: | Iris Versicolor 30C Homeopathic Remedy |
Brand: | Urenus |
Size: | 200 Pellets |
Ingredients: | Pure sucrose pellets, Lactose Free |
Manufacturing Method: | Prepared according to Hahnemann’s original procedure |
Dosage: | Place under the tongue; take apart from meals |
Safety: | No known side effects, no known drug interactions |
Reviews
There are no reviews yet.